197 related articles for article (PubMed ID: 27663616)
1. Osteoprotegerin-Knockout Mice Developed Early Onset Root Resorption.
Liu Y; Du H; Wang Y; Liu M; Deng S; Fan L; Zhang L; Sun Y; Zhang Q
J Endod; 2016 Oct; 42(10):1516-22. PubMed ID: 27663616
[TBL] [Abstract][Full Text] [Related]
2. Heparin enhances osteoclastic bone resorption by inhibiting osteoprotegerin activity.
Irie A; Takami M; Kubo H; Sekino-Suzuki N; Kasahara K; Sanai Y
Bone; 2007 Aug; 41(2):165-74. PubMed ID: 17560185
[TBL] [Abstract][Full Text] [Related]
3. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
[TBL] [Abstract][Full Text] [Related]
4. Expression of mRNA for osteoprotegerin and receptor activator of nuclear factor kappa beta ligand (RANKL) during root resorption induced by the application of heavy orthodontic forces on rat molars.
Low E; Zoellner H; Kharbanda OP; Darendeliler MA
Am J Orthod Dentofacial Orthop; 2005 Oct; 128(4):497-503. PubMed ID: 16214633
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of Wnt causes root resorption.
Lim WH; Liu B; Hunter DJ; Cheng D; Mah SJ; Helms JA
Am J Orthod Dentofacial Orthop; 2014 Sep; 146(3):337-45. PubMed ID: 25172256
[TBL] [Abstract][Full Text] [Related]
6. Osteoprotegerin deficiency attenuates strontium-mediated inhibition of osteoclastogenesis and bone resorption.
Peng S; Liu XS; Zhou G; Li Z; Luk KD; Guo XE; Lu WW
J Bone Miner Res; 2011 Jun; 26(6):1272-82. PubMed ID: 21611968
[TBL] [Abstract][Full Text] [Related]
7. Differentiation and functions of osteoclasts and odontoclasts in mineralized tissue resorption.
Sasaki T
Microsc Res Tech; 2003 Aug; 61(6):483-95. PubMed ID: 12879416
[TBL] [Abstract][Full Text] [Related]
8. MMP9 deficiency increased the size of experimentally induced apical periodontitis.
Wan C; Yuan G; Yang J; Sun Q; Zhang L; Zhang J; Zhang L; Chen Z
J Endod; 2014 May; 40(5):658-64. PubMed ID: 24767560
[TBL] [Abstract][Full Text] [Related]
9. Reduced Orthodontic Tooth Movement in Enpp1 Mutant Mice with Hypercementosis.
Wolf M; Ao M; Chavez MB; Kolli TN; Thumbigere-Math V; Becker K; Chu EY; Jäger A; Somerman MJ; Foster BL
J Dent Res; 2018 Jul; 97(8):937-945. PubMed ID: 29533727
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of osteoclast bone resorption activity through osteoprotegerin-induced damage of the sealing zone.
Song R; Gu J; Liu X; Zhu J; Wang Q; Gao Q; Zhang J; Cheng L; Tong X; Qi X; Yuan Y; Liu Z
Int J Mol Med; 2014 Sep; 34(3):856-62. PubMed ID: 25017214
[TBL] [Abstract][Full Text] [Related]
11. Toll-like receptor 2 knockout mice showed increased periapical lesion size and osteoclast number.
da Silva RA; Ferreira PD; De Rossi A; Nelson-Filho P; Silva LA
J Endod; 2012 Jun; 38(6):803-13. PubMed ID: 22595116
[TBL] [Abstract][Full Text] [Related]
12. Regulation of OPG and RANKL expressed by human dental follicle cells in osteoclastogenesis.
Sun H; Li Q; Zhang Y; Bi Y; Li X; Shu Y; Chen X; Jin Z; Ge C
Cell Tissue Res; 2015 Nov; 362(2):399-405. PubMed ID: 26149648
[TBL] [Abstract][Full Text] [Related]
13. Osteoprotective effects of osthole in a mouse model of 5/6 nephrectomy through inhibiting osteoclast formation.
Li X; Xue C; Wang L; Tang D; Huang J; Zhao Y; Chen Y; Zhao D; Shi Q; Wang Y; Shu B
Mol Med Rep; 2016 Oct; 14(4):3769-76. PubMed ID: 27571745
[TBL] [Abstract][Full Text] [Related]
14. Osteoprotegerin influences the bone resorption activity of osteoclasts.
Fu YX; Gu JH; Zhang YR; Tong XS; Zhao HY; Yuan Y; Liu XZ; Bian JC; Liu ZP
Int J Mol Med; 2013 Jun; 31(6):1411-7. PubMed ID: 23563320
[TBL] [Abstract][Full Text] [Related]
15. Expressions of RANKL/RANK and M-CSF/c-fms in root resorption lacunae in rat molar by heavy orthodontic force.
Nakano Y; Yamaguchi M; Fujita S; Asano M; Saito K; Kasai K
Eur J Orthod; 2011 Aug; 33(4):335-43. PubMed ID: 20833686
[TBL] [Abstract][Full Text] [Related]
16. Impaired bone resorption in cathepsin K-deficient mice is partially compensated for by enhanced osteoclastogenesis and increased expression of other proteases via an increased RANKL/OPG ratio.
Kiviranta R; Morko J; Alatalo SL; NicAmhlaoibh R; Risteli J; Laitala-Leinonen T; Vuorio E
Bone; 2005 Jan; 36(1):159-72. PubMed ID: 15664014
[TBL] [Abstract][Full Text] [Related]
17. The cross-talk between osteoclasts and osteoblasts in response to strontium treatment: involvement of osteoprotegerin.
Peng S; Liu XS; Huang S; Li Z; Pan H; Zhen W; Luk KD; Guo XE; Lu WW
Bone; 2011 Dec; 49(6):1290-8. PubMed ID: 21925296
[TBL] [Abstract][Full Text] [Related]
18. The role of parathyroid hormone-related protein in the regulation of osteoclastogenesis by cementoblasts.
Boabaid F; Berry JE; Koh AJ; Somerman MJ; McCcauley LK
J Periodontol; 2004 Sep; 75(9):1247-54. PubMed ID: 15515341
[TBL] [Abstract][Full Text] [Related]
19. Osteoprotegerin and osteoprotegerin ligand effects on osteoclast formation from human peripheral blood mononuclear cell precursors.
Shalhoub V; Faust J; Boyle WJ; Dunstan CR; Kelley M; Kaufman S; Scully S; Van G; Lacey DL
J Cell Biochem; 1999 Feb; 72(2):251-61. PubMed ID: 10022507
[TBL] [Abstract][Full Text] [Related]
20. Osteoclasts are not activated in middle ear cholesteatoma.
Koizumi H; Suzuki H; Ikezaki S; Ohbuchi T; Hashida K; Sakai A
J Bone Miner Metab; 2016 Mar; 34(2):193-200. PubMed ID: 25796629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
